RO91141B - Process for the preparation of 2-oxindol-1-carboxamide derivatives - Google Patents

Process for the preparation of 2-oxindol-1-carboxamide derivatives

Info

Publication number
RO91141B
RO91141B RO118604A RO11860485A RO91141B RO 91141 B RO91141 B RO 91141B RO 118604 A RO118604 A RO 118604A RO 11860485 A RO11860485 A RO 11860485A RO 91141 B RO91141 B RO 91141B
Authority
RO
Romania
Prior art keywords
phenyl
preparation
carboxamide derivatives
trifluoromethyl
methyl
Prior art date
Application number
RO118604A
Other languages
Romanian (ro)
Other versions
RO91141A (en
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of RO91141A publication Critical patent/RO91141A/en
Publication of RO91141B publication Critical patent/RO91141B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Inventia se refera la un procedeu pentru prepararea unor derivati de 2-oxindol-1-carboxamida cu formula generala I: ( vezi formula) în care R1 este metil, furil, tienil, trifluormetil, benzil, piridil, tienilmetil, ciclohexil, fenoximetil, feniletil, fenil, fenil substituit cu fluor, R2 este fenil, fenil mono sau disubstituit cu fluor, clor, trifluormetil, metoxi, metil sau etil, constînd din aceea ca un 2-oxindol cu formula generala II: (vezi formula) în care R1 are semnificatiile de mai sus, se trateaza cu un izocianat cu formula generala III: (vezi formula) în care R2 are semnificatiile de mai sus, în prezenta unui solvent, la o temperatura cuprinsa între temperatura camerei si cea de reflux, eventual în prezenta unui agent bazic, dupa care daca se doreste compusul cu formula I obtinut se transforma într-o sare acceptibila farmaceutic, prin metode în sine cunoscute.The invention relates to a process for the preparation of 2-oxindole-1-carboxamide derivatives of the general formula I wherein R 1 is methyl, furyl, thienyl, trifluoromethyl, benzyl, pyridyl, thienylmethyl, cyclohexyl, phenoxymethyl, phenylethyl , phenyl, phenyl substituted with fluorine, R 2 is phenyl, phenyl, mono- or di-substituted phenyl, phenyl, trifluoromethyl, methoxy, methyl or ethyl, the above-mentioned meaning is treated with an isocyanate of general formula III wherein R2 is as defined above in the presence of a solvent at a temperature between room temperature and reflux, optionally in the presence of an agent base, after which if desired, the compound of formula I obtained is converted into a pharmaceutically acceptable salt, by methods known per se.

RO118604A 1984-05-04 1985-05-03 Process for the preparation of 2-oxindol-1-carboxamide derivatives RO91141B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
RO91141A RO91141A (en) 1987-06-30
RO91141B true RO91141B (en) 1987-07-03

Family

ID=24431933

Family Applications (2)

Application Number Title Priority Date Filing Date
RO118604A RO91141B (en) 1984-05-04 1985-05-03 Process for the preparation of 2-oxindol-1-carboxamide derivatives
RO123678A RO94455B (en) 1984-05-04 1985-05-03 Process for preparing 2-oxindol-1-carboxamide derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
RO123678A RO94455B (en) 1984-05-04 1985-05-03 Process for preparing 2-oxindol-1-carboxamide derivatives

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO91141B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
KR850008154A (en) 1985-12-13
NO163132B (en) 1990-01-02
ZA853324B (en) 1986-12-30
ES542813A0 (en) 1986-07-16
CS252828B2 (en) 1987-10-15
ES8609248A1 (en) 1986-07-16
YU73085A (en) 1988-04-30
FI851756L (en) 1985-11-05
IE851103L (en) 1985-11-04
DD232916A5 (en) 1986-02-12
ES8707182A1 (en) 1987-07-16
JPS60243068A (en) 1985-12-03
PL257892A1 (en) 1986-10-07
IN161509B (en) 1987-12-19
MX5839A (en) 1993-11-01
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
NO851774L (en) 1985-11-05
KR870000497B1 (en) 1987-03-12
RO91141A (en) 1987-06-30
ZW7885A1 (en) 1985-07-24
YU44998B (en) 1991-06-30
NO163132C (en) 1990-04-11
RO94455B (en) 1988-07-01
BG60208B2 (en) 1993-12-30
SU1468413A3 (en) 1989-03-23
FI80016C (en) 1990-04-10
RU2017729C1 (en) 1994-08-15
CS320285A2 (en) 1987-03-12
MW1685A1 (en) 1986-09-10
PT80375A (en) 1985-05-01
OA08098A (en) 1987-03-31
PL253203A1 (en) 1986-06-17
RO94455A (en) 1988-06-30
EG17193A (en) 1990-08-30
HUT37754A (en) 1986-02-28
AR241159A1 (en) 1991-12-30
MA20424A1 (en) 1985-12-31
ES551275A0 (en) 1987-07-16
HU196057B (en) 1988-09-28
BG60207B2 (en) 1993-12-30
PL145416B1 (en) 1988-09-30
AR241159A2 (en) 1991-12-30
PT80375B (en) 1987-09-30
FI80016B (en) 1989-12-29
FI851756A0 (en) 1985-05-03

Similar Documents

Publication Publication Date Title
NO931151L (en) PROCEDURE FOR THE PREPARATION OF NITROGEN CONTAINING HETEROCYCLIC COMPOUNDS WITH CONDENSED RINGS
FI965126A0 (en) Tri-substituted phenyl derivative usable as PDE IV inhibitors
YU46915B (en) PROCEDURE FOR OBTAINING CALCIUM-INDEPENDENT CAMP PHOSPHODIESTERASE INHIBITORS
TR199901055T2 (en) Crystals of benzimidazole derivatives and their production.
DK104292A (en) HETEROCYCLIC COMPOUNDS AND PROCEDURES FOR THEIR PREPARATION
NO914558D0 (en) PREPARATION AND USE OF CONDENSED HETEROCYCLIC COMPOUND
KR860004918A (en) Method for preparing tricyclo compound
SE8204879D0 (en) NOVEL CHEMICAL INTERMEDIATES
MY105438A (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
BG34615A3 (en) METHOD FOR OBTAINING PENICILLANIC ACID 1-OXIDES
SE8401463D0 (en) NOVEL THIAZOLINE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
RO93218B (en) Process for preparing 2-oxindole derivatives
AT379800B (en) METHOD FOR PRODUCING NEW 2-OXACETIDINE DERIVATIVES
BG42004A3 (en) Method for preparing pyridyl compounds
MY101142A (en) 1, 4-dihydropyridine derivative, process for production thereof, and pharmaceutical use thereof.
GR1000156B (en) Preparation of new tricyclic amino derivatives of tetrahydro-5,6,7 naphtho-2,3
RO91141B (en) Process for the preparation of 2-oxindol-1-carboxamide derivatives
BG30927A3 (en) METHOD FOR PREPARATION OF TRANS-4-ALPHA-PHENYL-OCTAHYDRO-1H-2 PYRIDINES
BG29646A2 (en) 1,3-DISUBSTITUTED UREAS AND 2-THIOCUREAS, METHOD FOR THEIR PREPARATION AND THEIR APPLICATION
ES427277A1 (en) A PROCEDURE FOR THE PREPARATION OF A NEW MERCAPTOMETILPYRIDINE DERIVATIVE.
RO81937B (en) Process for the preparation of 7-beta-aminothiazolylacetamido-3-cephem-4-carboxylic acid derivatives
ES8204995A1 (en) 4,4-Disubstituted spiro-1,4-dihydropyridines, process for producing them and their use as intermediates.
RO85819B (en) Process for preparing methyl-quinoxaline-1,4-dioxide derivatives
IS3870A (en) Method of Preparation of Azetidinone Reagents, More Beneficial in Preparing Carbapenem Antibiotics
NO954070L (en) Method of Preparing